Giovanni G Camici
Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation.
Wenzl F, Kraler S, Ambler G, Weston C, Herzog S, Räber L, Muller O, Camici G, Roffi M, Rickli H, Fox K, de Belder M, Radovanovic D, Deanfield J, Lüscher T. Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation. Lancet 2022; 400:744-756.
29.08.2022Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation.
29.08.2022Lancet 2022; 400:744-756
Wenzl Florian A, Kraler Simon, Ambler Gareth, Weston Clive, Herzog Sereina A, Räber Lorenz, Muller Olivier, Camici Giovanni G, Roffi Marco, Rickli Hans, Fox Keith A A, de Belder Mark, Radovanovic Dragana, Deanfield John, Lüscher Thomas F
Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents
Camici G, Steffel J, Amanovic I, Breitenstein A, Baldinger J, Keller S, Lüscher T, Tanner F. Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. Eur Heart J 2009; 31:236-42.
29.06.2009Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents
29.06.2009Eur Heart J 2009; 31:236-42
Camici Giovanni G, Steffel Jan, Amanovic Ilijana, Breitenstein Alexander, Baldinger Jeannette, Keller Stephan, Lüscher Thomas F, Tanner Felix C
Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents
Camici G, Lüscher T, Yang Z, Matter C, Shojaati K, Schulz U, Baldinger J, Schafer N, Akhmedov A, Steffel J, Tanner F. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents. Circulation 2006; 114:1512-21.
25.09.2006Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents
25.09.2006Circulation 2006; 114:1512-21
Camici Giovanni G, Lüscher Thomas F, Yang Zhihong, Matter Christian M, Shojaati Kushiar, Schulz Urs, Baldinger Jeannette, Schafer Nicola, Akhmedov Alexander, Steffel Jan, Tanner Felix C